worldwide offices | contact | help | site map

Novartis Pharmaceuticals Corporation - A site intended for US audiences

 

 

 

Diseases & Conditions

PrintTell a FriendtextDecrease text sizeIncrease text size

Back to Index of Diseases & Conditions by Therapeutic Area

Schizophrenia

Understanding this condition

Schizophrenia is a group of serious brain disorders in which reality is interpreted abnormally. Schizophrenia results in hallucinations, delusions, and disordered thinking and behavior. People with schizophrenia withdraw from the people and activities in the world around them, retreating into an inner world marked by psychosis.

Contrary to popular belief, schizophrenia isn't the same as a split personality or multiple personality. While the word "schizophrenia" does means "split-mind," it refers to a disruption of the usual balance of emotions and thinking.

Schizophrenia is a chronic condition, requiring lifelong treatment. But thanks to new medications, schizophrenia symptoms can often be successfully managed, allowing people with the condition to lead productive, enjoyable lives.

Source: MayoClinic.com

 

Back to Index of Diseases & Conditions
 

OUR PRODUCTS

Products

Novartis is recognized worldwide for bringing to market innovative medicines with improved efficacy and fewer side-effects.

ACCESS TO MEDICINES

Access to Medicines

Novartis puts patients first. We want to create value for all patients, including those who cannot afford treatment. That is why we established Patient Assistance Now, a resource that allows you to access programs that may help you pay for your Novartis medicines.

PATIENT ASSISTANCE PROGRAMS

Patient Assistance Programs

Through our Patient Assistance Programs, we are committed to providing access to our medications for those most in need.